Department of Radiotherapy

Arshida, P.; Khan, Mohsin; Hussain, Bilal; Alam, Mehtab¹; Zaheer, Samreen; Alam, Shadab; Akram, Mohammad. Can Curcumin Achieve Radiosensitization Beyond that Achieved with Concurrent Chemotherapy in Head and Neck Cancers?. Amrita Journal of Medicine 21(4):p 221-231, October-December 2025. | DOI: 10.4103/AMJM.AMJM_34_25

Arshida, P.; Khan, Mohsin; Hussain, Bilal; Alam, Mehtab¹; Zaheer, Samreen; Alam, Shadab; Akram, Mohammad. Assessing the Protective Role of Nanocurcumin in Mitigating Acute Toxicities among Head-and-Neck Cancer Patients Receiving Concurrent Chemoradiation. Journal of Radiation and Cancer Research 16(4):p 162-168, Oct–Dec 2025. | DOI: 10.4103/jrcr.jrcr_11_25

Agrawal, A., Zaheer, S. & Akram, M. Chemoradiotherapy Plus High-dose-rate Intraluminal Brachytherapy Versus Chemoradiotherapy Alone in Locally Advanced Esophageal Carcinoma: A Single Center Experience with Limited Infrastructure. Indian J Surg Oncol (2025). https://doi.org/10.1007/s13193-025-02192-0

G K, Khan AA, Zaheer S, Ahuja S, Zaheer S. Evaluating Biomarker Dynamics in Breast Cancer Post-Neoadjuvant Chemotherapy: A Retrospective Cross-sectional Study: Biomarker Dynamics in Breast Cancer Post-NAC. Arch Breast Cancer [Internet]. 2024 Oct. 25 [cited 2025 Apr. 19];11(4). Available from: https://www.archbreastcancer.com/index.php/abc/article/view/986

Malik S, Sureka N, Ahuja S, Aden D, Zaheer S, Zaheer S. Tumor-associated macrophages: A sentinel of innate immune system in tumor microenvironment gone haywire. Cell Biol Int. 2024 Oct;48(10):1406-1449. doi: 10.1002/cbin.12226. Epub 2024 Jul 25. PMID: 39054741.

Aden D, Sureka N, Zaheer S, Chaurasia JK, Zaheer S. Metabolic Reprogramming in Cancer: Implications for Immunosuppressive Microenvironment. Immunology. 2025 Jan;174(1):30-72. doi: 10.1111/imm.13871. Epub 2024 Oct 27. PMID: 39462179.

Ahmad F, Akram M, Khan M. Concurrent chemoradiation with low-dose and long-duration weekly infusion of gemcitabine in unresectable squamous cell carcinoma of head and neck (SCCHN). J Cancer Res Ther. 2024 Apr 1;20(3):827-831. doi: 10.4103/jcrt.jcrt_2271_22. Epub 2024 Jun 27. PMID: 39023590.

Mohsin Khan , Zarmina Alam , Shahid Ali Siddiqui , Mohd Akram , Mohd Shadab Alam. Outcomes of Triple-Negative Breast Cancer Patients in Response to Taxane and Nontaxane-Based Neoadjuvant Chemotherapies. Asian Journal of Oncology. eFirst. DOI https://doi.org/ 10.1055/s-0042-1750086

Zarmina Alam, Mohsin Khan, Shahid Ali Siddiqui, Mohd Akram, Mohd Shadab Alam, M. A. Bilal Hussain. Hyperfractionated concurrent chemoradiation against conventional concurrent chemoradiation in locally advanced head and neck carcinoma: a prospective randomised trial. J Xiangya Med 2022;7:2

Mohsin Khan, M. A. Bilal Hussain, Shahid Ali Siddiqui, Mohd Akram. Five-year survival outcomes with two different high dose rate brachytherapy schedules used in the treatment of cervical carcinoma. Therapeutic Radiology and Oncology  2022;6:2